about
High mobility group box 1 protein interacts with multiple Toll-like receptorsTumor necrosis factor-alpha causes release of cytosolic interleukin-18 from human neutrophils.It's not your grandfather's field plasma.Fibrinolysis greater than 3% is the critical value for initiation of antifibrinolytic therapy.HMGB1 is markedly elevated within 6 hours of mechanical trauma in humans.Platelet-activating factor-mediated endosome formation causes membrane translocation of p67phox and p40phox that requires recruitment and activation of p38 MAPK, Rab5a, and phosphatidylinositol 3-kinase in human neutrophils.Stem cells and myocardial repair.Proteome and system ontology of hemorrhagic shock: exploring early constitutive changes in postshock mesenteric lymph.Validation of postinjury multiple organ failure scoresLysophosphatidylcholines activate G2A inducing G(αi)₋₁-/G(αq/)₁₁- Ca²(+) flux, G(βγ)-Hck activation and clathrin/β-arrestin-1/GRK6 recruitment in PMNs.Critical role of extracellular heat shock cognate protein 70 in the myocardial inflammatory response and cardiac dysfunction after global ischemia-reperfusion.The acute coagulopathy of trauma is due to impaired initial thrombin generation but not clot formation or clot strength.Viscoelastic clot strength predicts coagulation-related mortality within 15 minutesHypertonic saline inhibits arachidonic acid priming of the human neutrophil oxidase.Isoflurane prevents acute lung injury through ADP-mediated platelet inhibitionInsights from studies of blood substitutes in trauma.Structural organization of the neutrophil NADPH oxidase: phosphorylation and translocation during priming and activation.Elderly patients may benefit from tight glucose controlFunctional fibrinogen assay indicates that fibrinogen is critical in correcting abnormal clot strength following trauma.Antiplatelet therapy is associated with decreased transfusion-associated risk of lung dysfunction, multiple organ failure, and mortality in trauma patientsPlatelets are dominant contributors to hypercoagulability after injuryPostinjury hyperfibrinogenemia compromises efficacy of heparin-based venous thromboembolism prophylaxis.Plasma first in the field for postinjury hemorrhagic shock.Hypertonic saline attenuates TNF-alpha-induced NF-kappaB activation in pulmonary epithelial cells.Heme oxygenase-1 induction in macrophages by a hemoglobin-based oxygen carrier reduces endotoxin-stimulated cytokine secretion.Red blood cell supernatant potentiates LPS-induced proinflammatory cytokine response from peripheral blood mononuclear cells.Leukotriene b4 and its metabolites prime the neutrophil oxidase and induce proinflammatory activation of human pulmonary microvascular endothelial cells.Melanoma induces immunosuppression by up-regulating FOXP3(+) regulatory T cells.Nebulized hypertonic saline attenuates acute lung injury following trauma and hemorrhagic shock via inhibition of matrix metalloproteinase-13.Cross-transfusion of postshock mesenteric lymph provokes acute lung injuryDC maturation and function are not altered by melanoma-derived immunosuppressive soluble factors.Physiological levels of interleukin-18 stimulate multiple neutrophil functions through p38 MAP kinase activation.Monocyte chemotactic protein-1 directly induces human vascular smooth muscle proliferation.Postinjury life threatening coagulopathy: is 1:1 fresh frozen plasma:packed red blood cells the answer?Hemoglobin-based oxygen carrier induces hepatic heme oxygenase 1 expression in Kupffer cells.Glutamine attenuates endotoxin-induced lung metabolic dysfunction: potential role of enhanced heat shock protein 70.Lipopolysaccharide stimulation of human aortic valve interstitial cells activates inflammation and osteogenesis.Arachidonic acid in postshock mesenteric lymph induces pulmonary synthesis of leukotriene B4.Hemoglobin-based oxygen carrier induces heme oxygenase-1 in the heart and lung but not brain.IL-1beta induces an exaggerated pro- and anti-inflammatory response in peritoneal macrophages of children compared with adults.
P50
Q28280114-82B7DBE3-8400-4996-B81B-813B8062AD96Q33727625-410DF2D4-85B9-42C8-ABFD-FFF468642424Q33786828-8F06C7C1-BD79-466D-A9C8-D272745D045FQ33810788-08CE3E16-5791-4085-BA9E-8818EED144F9Q33898219-CC606819-FECE-484C-A00E-C006DBA4E25DQ34727676-8B67D7C0-3BA3-4578-BA0D-423E8E52E25FQ35000826-68A36628-F2B3-4093-83E4-5113B92C995FQ35038127-B20A6BA8-628F-49BA-B8EE-656715648FF8Q35072968-2A94A01D-DFC0-4514-B1F7-659E8C7BAB71Q35090466-4F0E81AC-2418-45FE-9ACB-6C2CF1130B3CQ35109063-065B6DB1-D45C-48AE-9A11-39B4915A0E99Q35161132-1587D885-39D7-45BF-BC1A-1506E0393188Q35192620-B9B37719-7039-45B7-9633-1608085A07A5Q35589539-84AD7F52-3A7F-4DF2-B576-11E836BE846BQ36164573-23F84F1B-20FC-492B-9DE1-54655284D90DQ36246297-48F568FF-E4AF-40D1-9113-F5E298E7F490Q36276584-305E5A70-A188-4E4F-93B1-CA0F321A4903Q36305509-A3D9953A-8E03-430E-9B1E-B94A2E26AB94Q36485509-8B3887B8-C5A8-40F5-9304-3240062A4467Q36569978-5E66CB92-E1AF-45CB-99FB-C7A68FF8EF90Q37078508-67ED878E-E994-48D7-8F0D-F01CB4714362Q37518149-30AB7128-B580-43F4-BACE-B8D5F23BD499Q37732197-76D75669-18C8-4296-848A-F80CEF582191Q39925897-1395F40E-63E8-4984-B7B2-CFD68B9E53D5Q39956155-6997A0ED-97C0-4EC4-8690-92B3BA064616Q41857948-B74C53D1-9F1B-444A-8A6F-2EA498DE5D4EQ41879867-D306009E-B714-43D1-B747-632FE8C6F151Q42106687-A165B780-787A-4B9C-B809-E2E7DA39E59CQ42406474-0E90DD2C-AEC9-4013-824F-CF1BD68C137CQ42862764-FC482B14-534E-44F7-BEF8-2CBA1C934C10Q43136973-6EA783EB-C778-4CAD-AB61-D62CBE721956Q44083748-437D6B05-122F-4824-9FD6-BCCBBA83E4BBQ44138410-8302B2BE-17D5-4F40-83E7-051182F161FFQ44491498-4480344D-38F6-49EA-9809-1162739E5845Q45008603-ED6CACD7-4452-4EEA-960D-EAC6843DDAD9Q45277007-78AFA80E-A260-46F3-9759-173E87EAAE6EQ46092054-F75C8076-08D0-4A51-9F7A-7C601FA22CDEQ46752450-4AB2DFD0-DB89-4B35-B36E-2F0FF4CBE62DQ47707094-B1BDFE7A-EEC6-490F-B11C-90CC86F2C1B0Q47715511-9907B53F-8642-4C87-827F-F8A3721A0928
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Anirban Banerjee
@ast
Anirban Banerjee
@en
Anirban Banerjee
@es
Anirban Banerjee
@nl
Anirban Banerjee
@sl
type
label
Anirban Banerjee
@ast
Anirban Banerjee
@en
Anirban Banerjee
@es
Anirban Banerjee
@nl
Anirban Banerjee
@sl
prefLabel
Anirban Banerjee
@ast
Anirban Banerjee
@en
Anirban Banerjee
@es
Anirban Banerjee
@nl
Anirban Banerjee
@sl
P106
P21
P31
P496
0000-0003-1690-2618
P569
2000-01-01T00:00:00Z